SmithKline unifies online buying

Goetzl, David
May 2000
Advertising Age;5/29/2000, Vol. 71 Issue 23, p6
Trade Publication
Reports that SmithKline Beecham has hired Jordan, McGrath, Case & Partners to coordinate an online media buying account. Details of the campaign, which include buying banner ads, sponsorships, and promotional opportunities across the Web for SmithKline Beecham's pharmaceutical and over-the-counter brands; Drug companies' past reluctance to advertise on the Internet, and expected growth in that area.


Related Articles

  • Coming of age. Thuermer, Karen // World Trade;Dec97, Vol. 10 Issue 12, p74 

    Provides information on pharmaceuticals and bio-tech companies in the United States. SmithKline Beecham's plan of building an office as the pharmaceutical company's existing U.S. headquarters; Key to moving operation from Europe to the United States; Factors that contributed to the growth of...

  • NEW MEDIA CHOICE / SOLSTIS. Timewell, Guy // Marketing (00253650);6/22/2000, p11 

    Comments on the Web site advertising for SmithKline Beecham PLC's liquid stimulant for insomniacs Solstis. Flaws in the Web design; Praise for some design strategies.

  • SKB makes quitting tougher in its smoking cessation ads.  // Medical Marketing & Media;Feb99, Vol. 34 Issue 2, p22 

    Reports on SmithKline Beecham (SKB) Corp.'s agreement with state governments in the United States, to end an investigation into advertising claims that its drug products ease smoking cessation efforts. SKB's plans to finance state public education campaign; Changes in SKB's advertising.

  • Androderm leaflet attacked by FDA. Dickinson, James G. // Medical Marketing & Media;Feb99, Vol. 34 Issue 2, p28 

    Reports on SmithKline & Beecham Corp.'s receipt of a notice from the United States Food & Drug Administration for a misleading information concerning its testosterone transdermal system.

  • Glaxo, SmithKline merger an intermediates boon? Milmo, Sean // Chemical Market Reporter;02/09/98, Vol. 253 Issue 6, p6 

    Examines the impact of a merger between Glaxo Inc. and SmithKline Beecham Corp. on pharmaceutical intermediate manufacturers in the United States. Speculation of the merged companies' greater reliance on marketing services offered by intermediate manufacturers; Reasons behind the two companies'...

  • One big, costly headache. Lloyd, Simon // BRW;06/16/2000, Vol. 22 Issue 23, p14 

    Reports on pharmaceutical firm SmithKline Beecham's recall of its Panadol and Panadeine products in Australia as of June 16, 2000. Company's handling of the issue; Plans for relaunching the products.

  • Branding fever strikes among prescription drugs. DeNitto, Emily // Advertising Age;11/22/1993, Vol. 64 Issue 49, p12 

    The article reports on a marketing trend that is emerging in the prescription drug market in the United States. Pharmaceutical companies are promoting their products to consumers through direct-to-consumer advertising, promotions and educational campaigns. Some examples include SmithKline...

  • Zit Drive. Greenberg, Karl // Adweek Eastern Edition;9/11/2000, Vol. 41 Issue 37, p76 

    Features an online advertising campaign created by interactive advertising agency Touch for SmithKline Beecham's acne medication called Oxy. Use of a branding message; Animated characters featured in the online advertisement; SmithKline's tie-up with teen-oriented music Web site MTV.com.

  • New wave of Rx industry consolidation may be near. Conlan, Michael F. // Drug Topics;2/16/98, Vol. 124 Issue 4, p18 

    Presents information on mergers in the United States' pharmaceutical industry, focusing on SmithKline Beecham's merger talks with American Home Products Corporation. Products made by SmithKline Beecham; Impact of news on this proposed merger; Comment from Hemant Shah, an independent stock...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics